Open Access<p>Dual SGLT1/SGLT2 Inhibitor Phlorizin Ameliorates Non-Alcoholic Fatty Liver Disease and Hepatic Glucose Production in Type 2 Diabetic Mice</p>
Author(s) -
Aline David-Silva,
João Victor Del Conti Esteves,
Mychel Morais,
Helayne Soares Freitas,
Telma Maria Tenório Zorn,
Maria Lúcia Côrrea-Giannella,
Ubiratan Fabres Machado
Publication year - 2020
Publication title -
diabetes, metabolic syndrome and obesity
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.853
H-Index - 43
ISSN - 1178-7007
DOI - 10.2147/dmso.s242282
Subject(s) - fatty liver , phlorizin , type 2 diabetes , medicine , alcoholic liver disease , endocrinology , diabetes mellitus , chemistry , disease , glucose transporter , insulin , cirrhosis